Endurance (cayman) Ltd Svf
10% Owner at Vir Biotechnology, Inc. (VIR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 3SEC | VIRVir Biotechnology, Inc. | Sell Plan | 191,85413,728,924 held (−1%) | $5.98 | $1.1M | +95.7% |
| Nov 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 227,80314,346,180 held (−2%) | $6.15 | $1.4M | +90.2% |
| Nov 26SEC | VIRVir Biotechnology, Inc. | Sell Plan | 235,97114,110,209 held (−2%) | $6.38 | $1.5M | +83.4% |
| Oct 30SEC | VIRVir Biotechnology, Inc. | Sell Plan | 24,45314,574,083 held (−0%) | $6.50 | $159K | +80.0% |
| Oct 30SEC | VIRVir Biotechnology, Inc. | Sell Plan | 10014,573,983 held (−0%) | $6.49 | $649 | +80.3% |
| Oct 22SEC | VIRVir Biotechnology, Inc. | Sell Plan | 220,53515,119,959 held (−1%) | $6.20 | $1.4M | +88.7% |
| Oct 22SEC | VIRVir Biotechnology, Inc. | Sell Plan | 109,67515,010,284 held (−1%) | $6.30 | $691K | +85.7% |
| Oct 17SEC | VIRVir Biotechnology, Inc. | Sell Plan | 16,67115,353,338 held (−0%) | $6.07 | $101K | +92.8% |
| Oct 17SEC | VIRVir Biotechnology, Inc. | Sell Plan | 12,84415,340,494 held (−0%) | $6.10 | $78K | +91.8% |
| Oct 7SEC | VIRVir Biotechnology, Inc. | Sell Plan | 450,34216,233,699 held (−3%) | $5.56 | $2.5M | +110.4% |
| Oct 7SEC | VIRVir Biotechnology, Inc. | Sell Plan | 73,95516,159,744 held (−0%) | $5.69 | $421K | +105.6% |
- Sell
10% Owner Endurance (cayman) Ltd Svf sold $1.1M of VIR at $5.98 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Endurance (cayman) Ltd Svf sold $1.4M of VIR at $6.15 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Endurance (cayman) Ltd Svf sold $1.5M of VIR at $6.38 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Endurance (cayman) Ltd Svf sold $159K of VIR at $6.50 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Endurance (cayman) Ltd Svf sold $649 of VIR at $6.49 — pre-scheduled 10b5-1 plan sale.
- Sell
10% Owner Endurance (cayman) Ltd Svf sold $1.4M of VIR at $6.20 — pre-scheduled 10b5-1 plan sale.